David N. Korones

University of Rochester Medical Center — United States

Medicine · Health Sciences

30h-index2.9kcitations148works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(47), Childhood Cancer Survivors' Quality of Life(31), Neuroblastoma Research and Treatments(21), Brain Metastases and Treatment(20), Palliative Care and End-of-Life Issues(19)

Publications148 total

CTP-15. Dordaviprone (ONC201) in a pediatric patient with recurrent H3 K27M-mutant diffuse glioma and leptomeningeal disease
Neuro-Oncology·2025Open Access
PDNO-01 Patterns, Clinical Presentations, and Time to Diagnosis in Pediatric Central Nervous System Tumors: Insights from a Pediatric Neuro-Oncology Tumor Board Team at a Tertiary Referral Hospital in Ethiopia
Neuro-Oncology Advances·2025Open Access
CTP-16. ONC201 (Dordaviprone) in the treatment of Diffuse Midline Glioma of the Pons in children: single center experience from Canada
Neuro-Oncology·2025Open Access
National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey
Journal of Neuro-Oncology·2025
The Art of the Art of Oncology
Journal of Clinical Oncology·2025
An atypical presentation of infiltrative diffuse low-grade glioma in an adolescent: case report
BMC Neurology·2025Open Access
Patterns, clinical presentations, and time to diagnosis in pediatric central nervous system tumors: insights from a pediatric neuro-oncology tumor board team at a tertiary referral hospital in Ethiopia
Journal of Neuro-Oncology·2025· 3 cited
Primary spinal cord astroblastoma: a case report and systematic review of the literature detailing management and understanding histopathological, epigenetic, and molecular analysis
Journal of Neurosurgery Pediatrics·2025
<i>PMS2</i> -related constitutional mismatch repair deficiency in a patient with unilateral retinoblastoma and negative germline <i>RB1</i>
Ophthalmic Genetics·2025· 1 cited
The Last Dose
New England Journal of Medicine·2025
“I’m as Mad as Hell and I’m Not Going to Take This Anymore!”
JAMA Neurology·2025
The impact of molecularly matched treatment and tumor mutational burden on pediatric brain tumor patient outcomes
2024Open Access
NCOG-07. SAFETY OF ONC201 TREATMENT IN PATIENTS WITH PREVIOUSLY TREATED H3 K27M-MUTANT GLIOMA: RESULTS FROM ONC028, AN ONGOING COMPASSIONATE USE PROGRAM
Neuro-Oncology·2024Open Access
IMMU-14. MULTI-INSTITUTION ANALYSIS OF TREATMENT MATCHING STATUS AND OUTCOMES IN PEDIATRIC CNS TUMOR PATIENTS
Neuro-Oncology·2024Open Access
Low-grade fibromyxoid tumor of the dura: A new entity?
Surgical Neurology International·2024Open Access
Talking to Children With Cancer: Sometimes Less Is More
2024
OUTC-02. CASE SERIES OF HYPERMUTATED PEDIATRIC CNS TUMORS
Neuro-Oncology·2023Open Access
Impact of Delay Prior to Treatment in Ethiopian Children with Acute Lymphoblastic Leukemia
Pediatric Health Medicine and Therapeutics·2023· 9 citedOpen Access
Pediatric ependymomas: Something old, something new
Pediatric Hematology Oncology Journal·2023· 9 citedOpen Access
Multi‐institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients
Pediatric Blood & Cancer·2022· 5 cited
page 1 of 8Next →

Frequent Co-authors

Michael T. Milano(6), Kevin A. Walter(4), Steven P. Meyers(4), Louis S. Constine(4), Paul Okunieff(3), Nimish Mohile(3), Paul G. Fisher(3), Webster H. Pilcher(3), Henry S. Friedman(3), Carlos F. Torres(3), Rajiv Mangla(2), Sven Ekholm(2), Joohee Sul(2), Mahlon D. Johnson(2), Amy Lee Bredlau(2), Robert H. Dworkin(2), Cynthia S. Kretschmar(2), Tianni Zhou(2), Zhengjia Chen(2), Carolyn Freeman(2)